Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ArriVent BioPharma Inc.
Swot
ArriVent BioPharma Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ArriVent BioPharma Inc. has 9 Strengths, 8 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(8)
Opportunity
(2)
Threats
(1)
Others
(0)
Price crossing above SMA20 today, and greater than SMA5
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Top Gainers
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
MFs decreased their shareholding last quarter
